QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donovan, B. J Articles by Pilcher, C. D Search for Related Content PubMed PubMed Citation Articles by Donovan, B. J Articles by Pilcher, C. D

AMBULATORY CARE

HIV Infection: Point-of-Care Testing

Manager, Infectious Diseases, Bristol-Myers Squibb Company, Princeton, NJ

John C Rublein, PharmD BCPS

Clinical Pharmacy Specialist, Infectious Diseases, Department of Pharmacy, University of North Carolina Hospitals; Clinical Assistant Professor of Pharmacy, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC

Peter A Leone, MD

Associate Professor of Medicine, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill; HIV/STD Prevention andCare Branch, North Carolina Department of Health and Human Services, Raleigh, NC

Christopher D Pilcher, MD

Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill

Reprints: Brian J Donovan PharmD BCPS, Bristol-Myers Squibb Company, PO Box 4500, Princeton, NJ 08543-4500, fax 609/897-6461, brian.donovan{at}bms.com

OBJECTIVE: To review the data regarding point-of-care testing for the diagnosis of HIV infection in the US.

DATA SOURCES: English-language literature was identified via MEDLINE (1980–August 2003) using key words such as rapid HIV tests and HIV antibody testing. Textbooks and other pertinent resources were also reviewed.

STUDY SELECTION AND DATA EXTRACTION: All articles identified through the data sources above were evaluated and reviewed if pertinent to the objective.

DATA SYNTHESIS: The Centers for Disease Control and Prevention (CDC) has announced an effort to expand currently recommended strategies to prevent new infections with HIV. The cornerstone of this initiative is the availability of the new rapid test for antibodies to HIV (OraQuick Rapid HIV-1 Antibody Test, OraSure Technologies, Bethlehem, PA). The effectiveness, sensitivity, and specificity of this test have been evaluated in a number of cross-sectional studies using previously or simultaneously performed HIV enzyme immunoassays with Western blot confirmation as a reference standard. Although there are several limitations to consider, results of these studies suggest that this test has comparable ability to detect HIV antibodies to other commercially available tests.

CONCLUSIONS: The OraQuick test is simple enough to be performed in many settings including those that facilitate achievement of the goals outlined by the CDC. Availability of this test should have a dramatic impact on HIV detection and prevention strategies.

Key Words: antibody testing, human immunodeficiency virus, OraQuick

Published Online, February 27, 2004. www.theannals.com, DOI 10.1345/aph.1D314

This article has been cited by other articles:

				A. E. Herr, A. V. Hatch, D. J. Throckmorton, H. M. Tran, J. S. Brennan, W. V. Giannobile, and A. K. Singh Microfluidic immunoassays as rapid saliva-based clinical diagnostics PNAS, March 27, 2007; 104(13): 5268 - 5273. [Abstract] [Full Text] [PDF]

				R. Lubelchek, K. Kroc, B. Hota, R. Sharief, U. Muppudi, J. Pulvirenti, and R. A. Weinstein The Role of Rapid vs Conventional Human Immunodeficiency Virus Testing for Inpatients: Effects on Quality of Care Arch Intern Med, September 26, 2005; 165(17): 1956 - 1960. [Abstract] [Full Text] [PDF]

				R. Chou, L. H. Huffman, R. Fu, A. K. Smits, and P. T. Korthuis Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, July 5, 2005; 143(1): 55 - 73. [Abstract] [Full Text] [PDF]